Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calmodulin (CaM) is a ubiquitous, highly conserved calcium-binding messenger protein that serves as a primary sensor of intracellular calcium levels in eukaryotic cells [3, 12]. Upon binding calcium ions, CaM undergoes a conformational change that allows it to interact with and regulate a wide array of target proteins, including kinases such as CaMKII and CaMKK, phosphatases like calcineurin, and various ion channels [3, 6, 14]. This signaling network, often referred to as Calmodulin-dependent signaling, is critical for diverse physiological processes including muscle contraction, synaptic plasticity, cell cycle progression, and inflammation [3, 18, 20]. Dysregulation of this pathway is implicated in various pathologies, notably cardiac arrhythmias and heart failure due to aberrant CaMKII activity, as well as several types of cancer where CaM-dependent kinases promote cell proliferation and survival [1, 5, 9, 13]. Pharmacological modulation has been explored using CaM antagonists like trifluoperazine and specific kinase inhibitors like KN-93, though the ubiquity of CaM presents significant challenges for achieving therapeutic selectivity and minimizing off-target effects [1, 12, 17]. In the heart, CaM-dependent signaling regulates excitation-contraction coupling, and its overactivation is a hallmark of maladaptive remodeling [5, 15, 19]. In the brain, it is essential for long-term potentiation and memory formation, making it a sensitive target for neurological side effects [3, 8, 14].
Calmodulin inhibition, CaMKII inhibition, and calcium-dependent binding to target proteins.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calmodulin (CaM) (CaM).